Found: 202
ОБЗОР2026 · pp. 79–86
Ivanova E.I., Chernyshova A.L., Sisakyan V.G., Tamkovich S.N.
Relevance. PARP inhibitors (PARPi), have emerged as a significant development in the treatment of high-grade serous ovarian cancer that is associated with mutations in BRCA1/2 and genes of other homologous recombination proteins. These drugs exploit synthetic …
ОБЗОР2026 · pp. 59–66
Demyashkin G.A., Belokopytov D.V., Shchekin V.I., Borovaya T.G., Rostovskaya V.V., Tsomartova D.A., Pyatigorskaya N.V., Filippova O.V., Maksarova D.D., Mirontsev A.V.
Introduction. Personalized treatment strategies for embryonal carcinoma, a germ cell tumor, are crucial due to the inherent heterogeneity of the tumor. Existing in vitro models inadequately reflect the native tumor microenvironment. Ex vivo organ culture (EVOC…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 53–58
Somonova O.V., Elizarova A.L., Vardanyan A.V.
Introduction. Cancer patients have a high risk of developing venous thromboembolic complications, which worsen the outcomes of antitumor treatment and are the second leading cause of death after cancer progression. Objectives – to assess the effect of modern a…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 24–33
Lapkina E.Z., Zinchenko I.S., Bondar Е.I., Ruksha T.G.
Introduction. Cancer drug resistance is driven among others, by non-genetic mechanisms. These processes may involve transcription factors dysregulation, modifications in gene expression, as well as epigenetic mechanisms such as DNA methylation, histone modific…
ОБЗОР2026 · pp. 57–64
Martusevich A.K., Tuzhilkin A.N., Chernysheva A.D., Popov A.V.
This review systematizes current data on branched-chain aminotransferases (BCATs). Their molecular structure, classification as fold type IV pyridoxal phosphate (PLP)-dependent enzymes, and catalytic features are discussed in detail. The differences between th…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2026 · pp. 52–56
Kaigorodova E.V., Kovalеv O.I., Grishchenko M.Y., Tulendinov E.R.
Introduction. Ovarian cancer is characterized by high mortality. Despite available diagnostic and therapeutic methods, patient survival remains unsatisfactory, especially for high-grade tumors, necessitating the exploration of new molecular targets. Heat shock…
ОБЗОР2026 · pp. 80–88
Kagirova E.M., Khusainova R.I., Mokrysheva N.G., Minniakhmetov I.R., Pavlov V.N.
Introduction. Breast cancer (BC) is a heterogeneous disease that represents a major global health problem. It is the most frequently diagnosed cancer in the world, with the incidence of breast cancer increasing year by year in most countries. The existence of …
ОБЗОР2026 · pp. 73–79
Ivanov A.A., Avdalyan A.M., Bakarev M.A., Lushnikova E.L., Rumyantseva M.B.
Introduction. Lymphogenous metastasis is a key stage in the progression of gastric cancer. The practice of personalized treatment has historically been based on histological and molecular analysis of the primary tumor, while the molecular-genetic landscape of …
ОБЗОР2026 · pp. 65–72
Barinov E.F.
The aim of the review is to analyze the main trends in the development of molecular medicine and to establish the dependence of the development of modern informative diagnostic tests and treatment methods on new knowledge about the biochemical processes develo…
ОБЗОР2025 · pp. 41–49
Olgin O.E., Zheravin A.A., Aliev M.D., Choynzonov E.L., Chernyshova A.L., Tamkovich S.N.
Relevance. Primary malignant neoplasms of bones and articular cartilage account for about 0.2% of all cancer cases and are characterized by an aggressive course, high tendency to metastasize, and resistance to therapy, which leads to unsatisfactory survival ra…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 3–9
Kryukova V.V., Tsepelev V.L., Tereshkov P.P.
The study of immune checkpoint expression by tumor microenvironment T-lymphocytes is necessary for understanding the pathophysiological mechanisms of tumor immunosuppression, as well as for the development of new methods of targeted therapy for colorectal canc…
ОБЗОР2025 · pp. 89–96
Baratova I.V., Bodunova N.A., Deeva T.A., Bordin D.S., Chebotareva M.V., Tsapkova L.A.
The aim of the study. To describe the interaction between Helicobacter pylori and Toll-like receptors, and to outline the role of TLRs gene polymorphisms in the pathogenesis of this infection. Material and methods. An analysis of publications from 2000 to 2025…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 79–88
Shrayner E.V., Bystrova V.I., Pokushalov E.A., Romanova A.D., Markin D.S., Kudlay D.A.
Introduction. Glutathione (GSH) is a key intracellular antioxidant involved in maintaining redox homeostasis, detoxifying xenobiotics, regulating immune and neurotransmitter systems, and supporting protein folding and degradation. Depletion of GSH is associate…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 70–78
Seliverstov P.V., Shapovalov V.V., Kravchuk Yu.A., Salikova S.P., Kupov S.S., Seliverstova T.N., Zadorozhnaya E.A., Mikeladze N.M., Kormschikova K.V.
Introduction. Chronic non-communicable diseases (NCDs) account for 75% of global mortality, while traditional treatment paradigm demonstrates inability to contain epidemiological burden. Artificial intelligence (AI) technologies combined with telemedicine enab…
ОБЗОР2025 · pp. 55–63
Evert L.S., Potupchik T.V., Saranchina Yu.V., Khadzieva M.K., Samoyavcheva V.S., Tsalikova R.R.
Introduction. Neurotoxicity is a common complication of chemotherapy that negatively affects the quality of life of cancer patients. Damage to the nervous system affects both the peripheral nerves (peripheral neuropathy) and the central nervous system (chemo b…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 77–85
Kudryashov G.G., Vinogradova T.I., Zmitrichenko Yu.G., Krylova Yu.S., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Tochilnikov G.V., Nefedov A.O., Agafonov G.M., Yablonskiy P.K.
Aim of the study. The possibility of using antitumor drugs against the background of active tuberculosis is an unresolved problem of modern medicine. The aim of the experimental study was to study the course of tuberculosis infection against the background of …
ОБЗОР2025 · pp. 30–38
Potupchik T.V., Usoltseva O.N., Kupov S.S., Veselova O.F., Efremova S.S., Baskakova E.S., Boyarko A.P.
The purpose of the study. To analyze scientific data on the molecular targets and mechanisms of action of key natural bioactive substances used to support cancer patients after chemotherapy and radiation therapy in the framework of personalized medicine. Perso…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 34–40
Kudriashov G.G., Krylova Yu.S., Zmitrichenko Yu.G., Tochilnikov G.V., Afafonov G.M., Vinogradova T.I., Yablonskii P.K.
Introduction. Up to 20% of tuberculosis patients suffer from malignant neoplasms. In this case, the combination of both diseases in the lung is a particular problem. More than 60% of patients cannot complete combination therapy due to drug-resistant MBT. The a…
ОБЗОР2025 · pp. 3–15
Seliverstov P.V., Ananyan M.A., Marchenko S.D., Stepanov M.R., Voznesenskaya E.A., Ilina K.V., Lyapustin K.Yu.
Introduction. Nanotechnology represents an innovative direction in cancer drug development, enabling the creation of effective drug delivery systems with enhanced therapeutic properties. Objective. To analyze the main types of nanoparticles used in oncology, e…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 68–74
Mikashinovich Z.I., Telesmanich N.R., Smirnova O.B.
Introduction. In clinical experiments with various pathologies leading to the activation of POL, it was found that one of the most important areas of correction of oxidative stress is the use of drugs with the properties of antioxidants and antihypoxants [6, 7…